- Home
- VCYT vs GRDN Comparison
VCYT vs GRDN Comparison
Compare VCYT & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCYT | GRDN |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Retail-Drug Stores and Proprietary Stores |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.7B |
| IPO Year | 2013 | 2023 |
Fundamental Metrics
Financial Performance| Metric | VCYT | GRDN |
|---|---|---|
| Price | $45.91 | $39.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 7 |
| Target Price | ★ $58.42 | $49.86 |
| AVG Volume (30 Days) | ★ 1.2M | 425.2K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 164.52 | N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | N/A | ★ $1,448,685,000.00 |
| Revenue This Year | $14.80 | N/A |
| Revenue Next Year | $10.94 | $6.35 |
| P/E Ratio | ★ $70.35 | $117.77 |
| Revenue Growth | N/A | ★ 17.93 |
| 52 Week Low | $29.46 | $26.34 |
| 52 Week High | $60.91 | $48.33 |
Technical Indicators
Market Signals| Indicator | VCYT | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 54.70 | 45.47 |
| Support Level | $39.96 | $38.49 |
| Resistance Level | $49.46 | $43.40 |
| Average True Range (ATR) | 2.32 | 1.49 |
| MACD | 0.16 | -0.14 |
| Stochastic Oscillator | 61.84 | 22.65 |
Price Performance
Historical ComparisonAbout VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
About GRDN Guardian Pharmacy Services Inc.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.